Jpmorgan Chase & Co »

Syndax Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 781k 21.61
2023-09-30 $11M 729k 14.52
2023-06-30 $16M 771k 20.94
2023-03-31 $10M 471k 21.13
2022-12-31 $14M 538k 25.45
2022-06-30 $11M 594k 19.24
2022-03-31 $4.2M 240k 17.38
2021-12-31 $3.7M 171k 21.83
2021-03-31 $209k 12k 17.86
2020-12-31 $580k 33k 17.86
2020-09-30 $141k 10k 14.04
2020-06-30 $135k 9.1k 14.79
2020-03-31 $1.2M 61k 18.87
2019-12-31 $413k 47k 8.80
2019-09-30 $271k 36k 7.46
2019-06-30 $50k 5.5k 9.05
2019-03-31 $19k 3.6k 5.25
2018-12-31 $16k 3.6k 4.47
2018-09-30 $86k 11k 8.14
2018-06-30 $1.9M 277k 7.02
2018-03-31 $6.1M 427k 14.23
2017-12-31 $3.6M 405k 8.76
2017-06-30 $6.1M 439k 13.97
2017-03-31 $53k 3.9k 13.72
2016-12-31 $73k 10k 7.17
2016-06-30 $5.0k 505 9.90